Trevi Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $3.5M | 379k | 9.15 |
| 2025-06-30 | $8.8M | 1.6M | 5.47 |
| 2025-03-31 | $857k | 136k | 6.29 |
| 2024-12-31 | $5.4M | 1.3M | 4.12 |
| 2024-09-30 | $184k | 55k | 3.34 |
| 2024-03-31 | $109k | 32k | 3.45 |
| 2023-12-31 | $254k | 190k | 1.34 |
| 2023-09-30 | $59k | 27k | 2.18 |
| 2023-06-30 | $147k | 62k | 2.39 |
| 2023-03-31 | $222k | 120k | 1.85 |
| 2022-12-31 | $110k | 57k | 1.93 |
| 2021-12-31 | $39k | 50k | 0.78 |
| 2021-09-30 | $25k | 18k | 1.38 |
| 2021-03-31 | $29k | 11k | 2.73 |